Literature DB >> 28132099

PCSK9 inhibition and the global diabetes epidemic.

Luca Mascitelli1, Mark R Goldstein2.   

Abstract

Entities:  

Keywords:  Cardiovascular disease; Diabetes risk; Epidemiology; Monoclonal antibody; PCSK9

Mesh：

Substances：

Year:  2017        PMID： 28132099     DOI： 10.1007/s00125-017-4217-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

1.  Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study.

Authors:  E J Sijbrands; R G Westendorp; J C Defesche; P H de Meier; A H Smelt; J J Kastelein
Journal:  BMJ       Date:  2001-04-28

2.  Recent Trends in Cardiovascular Mortality in the United States and Public Health Goals.

Authors:  Stephen Sidney; Charles P Quesenberry; Marc G Jaffe; Michael Sorel; Mai N Nguyen-Huynh; Lawrence H Kushi; Alan S Go; Jamal S Rana
Journal:  JAMA Cardiol       Date:  2016-08-01       Impact factor: 14.676

3.  Evidence that men with familial hypercholesterolemia can avoid early coronary death. An analysis of 77 gene carriers in four Utah pedigrees.

Authors:  R R Williams; S J Hasstedt; D E Wilson; K O Ash; F F Yanowitz; G E Reiber; H Kuida
Journal:  JAMA       Date:  1986-01-10       Impact factor: 56.272

4.  PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study.

Authors:  Amand F Schmidt; Daniel I Swerdlow; Michael V Holmes; Riyaz S Patel; Zammy Fairhurst-Hunter; Donald M Lyall; Fernando Pires Hartwig; Bernardo Lessa Horta; Elina Hyppönen; Christine Power; Max Moldovan; Erik van Iperen; G Kees Hovingh; Ilja Demuth; Kristina Norman; Elisabeth Steinhagen-Thiessen; Juri Demuth; Lars Bertram; Tian Liu; Stefan Coassin; Johann Willeit; Stefan Kiechl; Karin Willeit; Dan Mason; John Wright; Richard Morris; Goya Wanamethee; Peter Whincup; Yoav Ben-Shlomo; Stela McLachlan; Jackie F Price; Mika Kivimaki; Catherine Welch; Adelaida Sanchez-Galvez; Pedro Marques-Vidal; Andrew Nicolaides; Andrie G Panayiotou; N Charlotte Onland-Moret; Yvonne T van der Schouw; Giuseppe Matullo; Giovanni Fiorito; Simonetta Guarrera; Carlotta Sacerdote; Nicholas J Wareham; Claudia Langenberg; Robert Scott; Jian'an Luan; Martin Bobak; Sofia Malyutina; Andrzej Pająk; Ruzena Kubinova; Abdonas Tamosiunas; Hynek Pikhart; Lise Lotte Nystrup Husemoen; Niels Grarup; Oluf Pedersen; Torben Hansen; Allan Linneberg; Kenneth Starup Simonsen; Jackie Cooper; Steve E Humphries; Murray Brilliant; Terrie Kitchner; Hakon Hakonarson; David S Carrell; Catherine A McCarty; H Lester Kirchner; Eric B Larson; David R Crosslin; Mariza de Andrade; Dan M Roden; Joshua C Denny; Cara Carty; Stephen Hancock; John Attia; Elizabeth Holliday; Martin O'Donnell; Salim Yusuf; Michael Chong; Guillaume Pare; Pim van der Harst; M Abdullah Said; Ruben N Eppinga; Niek Verweij; Harold Snieder; Tim Christen; Dennis O Mook-Kanamori; Stefan Gustafsson; Lars Lind; Erik Ingelsson; Raha Pazoki; Oscar Franco; Albert Hofman; Andre Uitterlinden; Abbas Dehghan; Alexander Teumer; Sebastian Baumeister; Marcus Dörr; Markus M Lerch; Uwe Völker; Henry Völzke; Joey Ward; Jill P Pell; Daniel J Smith; Tom Meade; Anke H Maitland-van der Zee; Ekaterina V Baranova; Robin Young; Ian Ford; Archie Campbell; Sandosh Padmanabhan; Michiel L Bots; Diederick E Grobbee; Philippe Froguel; Dorothée Thuillier; Beverley Balkau; Amélie Bonnefond; Bertrand Cariou; Melissa Smart; Yanchun Bao; Meena Kumari; Anubha Mahajan; Paul M Ridker; Daniel I Chasman; Alex P Reiner; Leslie A Lange; Marylyn D Ritchie; Folkert W Asselbergs; Juan-Pablo Casas; Brendan J Keating; David Preiss; Aroon D Hingorani; Naveed Sattar
Journal:  Lancet Diabetes Endocrinol       Date:  2016-11-29       Impact factor: 32.069

Review 5.  PCSK9 inhibition: the dawn of a new age in cholesterol lowering?

Authors:  David Preiss; Marion Mafham
Journal:  Diabetologia       Date:  2016-12-26       Impact factor: 10.122

6.  Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.

Authors:  Brian A Ference; Jennifer G Robinson; Robert D Brook; Alberico L Catapano; M John Chapman; David R Neff; Szilard Voros; Robert P Giugliano; George Davey Smith; Sergio Fazio; Marc S Sabatine
Journal:  N Engl J Med       Date:  2016-12-01       Impact factor: 91.245
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.